![Dr. James Underberg(@lipiddoc) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
Dr. James Underberg
@lipiddoc
Lipidologist🩺🧬 @nyulangone @NYUCVDPrevent PastPresident @NationalLipid & @LipidBoard President @NLAFoundation Dir. @BHLipidClinic T/RT≠endorsements/med advice
ID:42383845
https://linktr.ee/LipidDoc 25-05-2009 10:19:41
22,6K Tweets
13,5K Followers
8,9K Following
![National Lipid Association(@nationallipid) 's Twitter Profile Photo National Lipid Association(@nationallipid) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1261349220239446016/24VjmDus_200x200.jpg)
Going to #NLASessions ? We have your Friday night covered! Support the Foundation of the NLA and bid on 2 tickets to Cirque du Soleil 'O'
nlafoundation.com
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
Thanks Pablo Corral MD for sharing this - Observational data & diet recall but compelling no less ! Of note those with ⬆️ Polygenic 🧬 Risk score for High Cholesterol did worse ( ? Hyper-absorbers ) .
![Dr. James Underberg (@lipiddoc) on Twitter photo 2024-05-18 15:51:12 Thanks @drpablocorral for sharing this - Observational data & diet recall but compelling no less ! Of note those with ⬆️ Polygenic 🧬 Risk score for High Cholesterol did worse ( ? Hyper-absorbers ) . Thanks @drpablocorral for sharing this - Observational data & diet recall but compelling no less ! Of note those with ⬆️ Polygenic 🧬 Risk score for High Cholesterol did worse ( ? Hyper-absorbers ) .](https://pbs.twimg.com/media/GN32V6sXIAA3SfO.jpg)
![Prof Kausik Ray FMedSci(@ProfKausikRay) 's Twitter Profile Photo Prof Kausik Ray FMedSci(@ProfKausikRay) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1652556182425305090/z8da_L38_200x200.jpg)
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
Association of lipoprotein(a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis academic-oup-com.ezproxy.med.nyu.edu/eurjpc/article… Yet another reason to measure ! NYU CVD Prevention National Lipid Association Family Heart Foundation Foundation of the NLA #testlpa Via European Society of Cardiology Journals
![Dr. James Underberg (@lipiddoc) on Twitter photo 2024-05-15 10:21:51 Association of lipoprotein(a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis academic-oup-com.ezproxy.med.nyu.edu/eurjpc/article… Yet another reason to measure ! @NYUCVDPrevent @nationallipid @TheFHFoundation @foundationofnla #testlpa Via @ESC_Journals Association of lipoprotein(a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis academic-oup-com.ezproxy.med.nyu.edu/eurjpc/article… Yet another reason to measure ! @NYUCVDPrevent @nationallipid @TheFHFoundation @foundationofnla #testlpa Via @ESC_Journals](https://pbs.twimg.com/media/GNnNZQVXYAADerM.jpg)
![NYU CVD Prevention(@NYUCVDPrevent) 's Twitter Profile Photo NYU CVD Prevention(@NYUCVDPrevent) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/888025326437122048/Uvfc-Erk_200x200.jpg)
![Vindico Medical Education(@VindicoMedEd) 's Twitter Profile Photo Vindico Medical Education(@VindicoMedEd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/804933284/V10-0133_VME_2010_Twitter_Picture_200x200.png)
Can't make it to Vegas for #NLASessions ?
Join us virtually on Thursday, 5/30 to broaden your understanding of the complex nature of hyperlipidemia management: ow.ly/UBiW50RihOg
National Lipid Association Alan Brown MD MHA FACC FNLA Dr. James Underberg Christie Ballantyne Dr. Payal Kohli, MD
![Vindico Medical Education (@VindicoMedEd) on Twitter photo 2024-05-10 13:00:52 Can't make it to Vegas for #NLASessions? Join us virtually on Thursday, 5/30 to broaden your understanding of the complex nature of hyperlipidemia management: ow.ly/UBiW50RihOg @nationallipid @alanbrownmd @lipiddoc @CBallantyneMD @payalkohlimd Can't make it to Vegas for #NLASessions? Join us virtually on Thursday, 5/30 to broaden your understanding of the complex nature of hyperlipidemia management: ow.ly/UBiW50RihOg @nationallipid @alanbrownmd @lipiddoc @CBallantyneMD @payalkohlimd](https://pbs.twimg.com/media/GNOCo91XQAANRqi.jpg)
![Medlive(@medliveofficial) 's Twitter Profile Photo Medlive(@medliveofficial) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1668653747839414280/n8KiPDbf_200x200.jpg)
You can now watch our FREE on-demand #CME program with National Lipid Association! Join Dr. James Underberg (@lipiddoc), Dr. Alan Brown (@alanbrownmd), and Dr. Christie Ballantyne (@CBallantyneMD) for this discussion on #CETPinhibition ➡️ bit.ly/4bp07xh
![NORD(@RareDiseases) 's Twitter Profile Photo NORD(@RareDiseases) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1487095722705133573/Vb3Oo2MX_200x200.jpg)
Join NORD and Medlive for 8 easy-to-digest, on-demand #CME modules covering gene and cell therapies for several relevant disease states. Expert clinicians lead each module and review relevant data.
Start here: bit.ly/3w56Qxu
#CellTherapy #GeneTherapy
![NORD (@RareDiseases) on Twitter photo 2024-05-06 18:35:06 Join NORD and @medliveofficial for 8 easy-to-digest, on-demand #CME modules covering gene and cell therapies for several relevant disease states. Expert clinicians lead each module and review relevant data. Start here: bit.ly/3w56Qxu #CellTherapy #GeneTherapy Join NORD and @medliveofficial for 8 easy-to-digest, on-demand #CME modules covering gene and cell therapies for several relevant disease states. Expert clinicians lead each module and review relevant data. Start here: bit.ly/3w56Qxu #CellTherapy #GeneTherapy](https://pbs.twimg.com/media/GM6owxyX0AAlCwL.jpg)
![Medlive(@medliveofficial) 's Twitter Profile Photo Medlive(@medliveofficial) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1668653747839414280/n8KiPDbf_200x200.jpg)
Coming 5/9/24: Watch our FREE on-demand #CME program with National Lipid Association on #CETP inhibition as a promising mechanism for reducing residual LDL-C elevation in patients at high cardiovascular risk ➡️ bit.ly/4bp07xh
🏷️ #MedicalEducation #MedEd #FreeCME #CVDisease
![Medlive (@medliveofficial) on Twitter photo 2024-05-06 21:30:05 Coming 5/9/24: Watch our FREE on-demand #CME program with @nationallipid on #CETP inhibition as a promising mechanism for reducing residual LDL-C elevation in patients at high cardiovascular risk ➡️ bit.ly/4bp07xh 🏷️ #MedicalEducation #MedEd #FreeCME #CVDisease Coming 5/9/24: Watch our FREE on-demand #CME program with @nationallipid on #CETP inhibition as a promising mechanism for reducing residual LDL-C elevation in patients at high cardiovascular risk ➡️ bit.ly/4bp07xh 🏷️ #MedicalEducation #MedEd #FreeCME #CVDisease](https://pbs.twimg.com/media/GM7Q1EuXQAEYFEp.jpg)
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
Sex differences in lipids: A life course approach - via Atherosclerosis #Atherosclerosis atherosclerosis-journal.com/article/S0021-… NYU CVD Prevention National Lipid Association Foundation of the NLA Family Heart Foundation
![Dr. James Underberg (@lipiddoc) on Twitter photo 2024-05-04 15:22:14 Sex differences in lipids: A life course approach - via @ATHjournal #Atherosclerosis atherosclerosis-journal.com/article/S0021-… @NYUCVDPrevent @nationallipid @foundationofnla @TheFHFoundation Sex differences in lipids: A life course approach - via @ATHjournal #Atherosclerosis atherosclerosis-journal.com/article/S0021-… @NYUCVDPrevent @nationallipid @foundationofnla @TheFHFoundation](https://pbs.twimg.com/media/GMvpdODWoAAEwBF.jpg)
![Eric Topol(@EricTopol) 's Twitter Profile Photo Eric Topol(@EricTopol) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1589325138960318464/2OwvQAWC_200x200.jpg)
How to diagnose rare diseases more accurately?
Use #AI
As shown with a new tool ai.marrvel.org
ai.nejm.org/doi/full/10.10…
Dongxue Mao Zhandong Liu Chaozhong Liu
Linhua (Alex) Wang sasidhar pasupuleti Rami Al-Ouran and colleagues BCMHouston NEJM AI
![NYU CVD Prevention(@NYUCVDPrevent) 's Twitter Profile Photo NYU CVD Prevention(@NYUCVDPrevent) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/888025326437122048/Uvfc-Erk_200x200.jpg)
New Publication! Potential global implementation of #colchicine to target residual #inflammation in #CAD .
Kudos to Dr Michael Garshick, NYU Grossman School of Medicine cardiology fellow Dr Robert Zhang + collaborators Dr Brittany Weber and Dr Diego Araiza-Garaygordobil!
bit.ly/4cLBGLU
![NYU CVD Prevention (@NYUCVDPrevent) on Twitter photo 2024-04-08 13:50:54 New Publication! Potential global implementation of #colchicine to target residual #inflammation in #CAD. Kudos to Dr Michael Garshick, @nyugrossman cardiology fellow Dr Robert Zhang + collaborators Dr Brittany Weber and Dr Diego Araiza-Garaygordobil! bit.ly/4cLBGLU New Publication! Potential global implementation of #colchicine to target residual #inflammation in #CAD. Kudos to Dr Michael Garshick, @nyugrossman cardiology fellow Dr Robert Zhang + collaborators Dr Brittany Weber and Dr Diego Araiza-Garaygordobil! bit.ly/4cLBGLU](https://pbs.twimg.com/media/GKpWPJHXEAAbTjf.jpg)
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
Data from Bridge-TIMI 73a LBCT #Triglycerides reduced by 50% . Good safety Data. Via NEJM TIMI Study Group #ACC24 #lipids NYU CVD Prevention National Lipid Association Foundation of the NLA
![Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦(@pabeda1) 's Twitter Profile Photo Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦(@pabeda1) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1695448885865439232/K2oSjji7_200x200.jpg)
#ACC24 Gregory Schwartz reminds ud that Ezetimibe is still underutilized and can add substantial benefits to reduce ASCVD outcomes when added to statins or other LDLc lowering therapies! #CardioTwitter #Cardiology
![Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 (@pabeda1) on Twitter photo 2024-04-06 16:28:55 #ACC24 Gregory Schwartz reminds ud that Ezetimibe is still underutilized and can add substantial benefits to reduce ASCVD outcomes when added to statins or other LDLc lowering therapies! #CardioTwitter #Cardiology #ACC24 Gregory Schwartz reminds ud that Ezetimibe is still underutilized and can add substantial benefits to reduce ASCVD outcomes when added to statins or other LDLc lowering therapies! #CardioTwitter #Cardiology](https://pbs.twimg.com/media/GKfsNIvWgAA-UHE.jpg)
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
In FOURIER, intensive LDL-C lowering with #evolocumab led to greater CV event reduction in patients with autoimmune or inflammatory diseases. These patients may derive particular benefit from earlier, more intensive lipid-lowering treatments. Robert Giugliano André Zimerman #ACC24
![TIMI Study Group (@TIMIStudyGroup) on Twitter photo 2024-04-06 16:10:12 In FOURIER, intensive LDL-C lowering with #evolocumab led to greater CV event reduction in patients with autoimmune or inflammatory diseases. These patients may derive particular benefit from earlier, more intensive lipid-lowering treatments. @rgiugliano @AndreZimerman #ACC24 In FOURIER, intensive LDL-C lowering with #evolocumab led to greater CV event reduction in patients with autoimmune or inflammatory diseases. These patients may derive particular benefit from earlier, more intensive lipid-lowering treatments. @rgiugliano @AndreZimerman #ACC24](https://pbs.twimg.com/media/GKfn7BjWEAAA-3D.jpg)
![Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo Dr. James Underberg(@lipiddoc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672331057197199360/uKkMXHcB_200x200.jpg)
Nice overview 👏of HDL space by Christie Ballantyne vijay nambi - “ injured reserve” HDL structure pic via Thomas Dayspring
![Dr. James Underberg (@lipiddoc) on Twitter photo 2024-04-07 11:02:22 Nice overview 👏of HDL space by @CBallantyneMD @vijay_nambi - “ injured reserve” HDL structure pic via @Drlipid Nice overview 👏of HDL space by @CBallantyneMD @vijay_nambi - “ injured reserve” HDL structure pic via @Drlipid](https://pbs.twimg.com/media/GKjrDB5WEAA_WVJ.jpg)